273 related articles for article (PubMed ID: 2369741)
1. Differing specificities for 4-aminofolate analogues of folylpolyglutamyl synthetase from tumors and proliferative intestinal epithelium of the mouse with significance for selective antitumor action.
Rumberger BG; Barrueco JR; Sirotnak FM
Cancer Res; 1990 Aug; 50(15):4639-43. PubMed ID: 2369741
[TBL] [Abstract][Full Text] [Related]
2. Structural design, biochemical properties, and evidence for improved therapeutic activity of 5-alkyl derivatives of 5-deazaaminopterin and 5-deazamethotrexate compared to methotrexate in murine tumor models.
Sirotnak FM; Schmid FA; Otter GM; Piper JR; Montgomery JA
Cancer Res; 1988 Oct; 48(20):5686-91. PubMed ID: 3167828
[TBL] [Abstract][Full Text] [Related]
3. Similar differential for total polyglutamylation and cytotoxicity among various folate analogues in human and murine tumor cells in vitro.
Samuels LL; Moccio DM; Sirotnak FM
Cancer Res; 1985 Apr; 45(4):1488-95. PubMed ID: 3978616
[TBL] [Abstract][Full Text] [Related]
4. Hydrolytic cleavage of methotrexate gamma-polyglutamates by folylpolyglutamyl hydrolase derived from various tumors and normal tissues of the mouse.
Samuels LL; Goutas LJ; Priest DG; Piper JR; Sirotnak FM
Cancer Res; 1986 May; 46(5):2230-5. PubMed ID: 2421872
[TBL] [Abstract][Full Text] [Related]
5. Preferential selection during therapy in vivo by edatrexate compared to methotrexate of resistant L1210 cell variants with decreased folylpolyglutamate synthetase activity.
Rumberger BG; Schmid FA; Otter GM; Sirotnak FM
Cancer Commun; 1990; 2(9):305-10. PubMed ID: 2206778
[TBL] [Abstract][Full Text] [Related]
6. Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity.
Westerhof GR; Schornagel JH; Kathmann I; Jackman AL; Rosowsky A; Forsch RA; Hynes JB; Boyle FT; Peters GJ; Pinedo HM
Mol Pharmacol; 1995 Sep; 48(3):459-71. PubMed ID: 7565626
[TBL] [Abstract][Full Text] [Related]
7. Folate analogues as substrates of mammalian folylpolyglutamate synthetase.
Schoo MM; Pristupa ZB; Vickers PJ; Scrimgeour KG
Cancer Res; 1985 Jul; 45(7):3034-41. PubMed ID: 3873989
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory action of 10-deazaaminopterins and their polyglutamates on human thymidylate synthase.
Ueda T; Dutschman GE; Nair MG; Degraw JI; Sirotnak FM; Cheng YC
Mol Pharmacol; 1986 Aug; 30(2):149-53. PubMed ID: 2426568
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biologic activity of new side-chain-altered methotrexate and aminopterin analogs with dual inhibitory action against dihydrofolate reductase and folylpolyglutamate synthetase.
Rosowsky A; Moran RG; Freisheim JH; Bader H; Forsch RA; Solan VC
NCI Monogr; 1987; (5):145-52. PubMed ID: 3431589
[TBL] [Abstract][Full Text] [Related]
10. Further evidence for a basis of selective activity and relative responsiveness during antifolate therapy of murine tumors.
Sirotnak FM; Donsback RC
Cancer Res; 1975 Jul; 35(7):1737-44. PubMed ID: 1169115
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of histidine analogues of folic acid and methotrexate as potential folylpolyglutamate synthetase inhibitors.
Mao Z; Pan J; Kalman TI
J Med Chem; 1996 Oct; 39(21):4340-4. PubMed ID: 8863812
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate analogues. 26. Inhibition of dihydrofolate reductase and folylpolyglutamate synthetase activity and in vitro tumor cell growth by methotrexate and aminopterin analogues containing a basic amino acid side chain.
Rosowsky A; Freisheim JH; Moran RG; Solan VC; Bader H; Wright JE; Radike-Smith M
J Med Chem; 1986 May; 29(5):655-60. PubMed ID: 2871191
[TBL] [Abstract][Full Text] [Related]
13. Structural features of 4-amino antifolates required for substrate activity with mammalian folylpolyglutamate synthetase.
Moran RG; Colman PD; Rosowsky A; Forsch RA; Chan KK
Mol Pharmacol; 1985 Jan; 27(1):156-66. PubMed ID: 3838105
[TBL] [Abstract][Full Text] [Related]
14. Analogues of methotrexate in rheumatoid arthritis. 2. Effects of 5-deazaaminopterin, 5,10-dideazaaminopterin, and analogues on type II collagen-induced arthritis in mice.
Piper JR; DeGraw JI; Colwell WT; Johnson CA; Smith RL; Waud WR; Sirotnak FM
J Med Chem; 1997 Jan; 40(3):377-84. PubMed ID: 9022805
[TBL] [Abstract][Full Text] [Related]
15. Similar characteristics of folate analogue transport in vitro in contrast to varying dihydrofolate reductase levels in epithelial cells at different stages of maturation in mouse small intestine.
Sirotnak FM; Moccio DM; Yang CH
Cancer Res; 1984 Nov; 44(11):5204-11. PubMed ID: 6488181
[TBL] [Abstract][Full Text] [Related]
16. Similar specificity of membrane transport for folate analogues and their metabolites by murine and human tumor cells: a clinically directed laboratory study.
Moccio DM; Sirotnak FM; Samuels LL; Ahmed T; Yagoda A; DeGraw JI; Piper JR
Cancer Res; 1984 Jan; 44(1):352-7. PubMed ID: 6690047
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity, uptake, polyglutamate formation, and antileukemic effects of 8-deaza analogues of methotrexate and aminopterin in mice.
Kuehl M; Brixner DI; Broom AD; Avery TL; Blakley RL
Cancer Res; 1988 Mar; 48(6):1481-8. PubMed ID: 2449950
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate analogues. 34. Replacement of the glutamate moiety in methotrexate and aminopterin by long-chain 2-aminoalkanedioic acids.
Rosowsky A; Bader H; Kohler W; Freisheim JH; Moran RG
J Med Chem; 1988 Jul; 31(7):1338-44. PubMed ID: 2898531
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of DL-4,4-difluoroglutamic acid and DL-gamma,gamma-difluoromethotrexate.
Tsukamoto T; Kitazume T; McGuire JJ; Coward JK
J Med Chem; 1996 Jan; 39(1):66-72. PubMed ID: 8568828
[TBL] [Abstract][Full Text] [Related]
20. Screening of colon tumor cells and tissues for folylpolyglutamate synthetase activity.
van der Wilt CL; Cloos J; de Jong M; Pinedo HM; Peters GJ
Oncol Res; 1995; 7(6):317-21. PubMed ID: 8527866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
